Specific insulin assays, insulin sensitivity and blood pressure

QJM: An International Journal of Medicine

Volumn 90, Issue 7, 1997, Pages 465-475

  Petrie, J R ^a,d   Morris, A D ^b   Dorrian, C A ^c   Small, M ^c   Connell, J M C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROINSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSAY; BLOOD PRESSURE; CONTROLLED STUDY; CROSS REACTION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030863528     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.7.465     Document Type: Article

References (37)

1. Reaven CM. Role of insulin resistance in human disease. Diabetes 1988; 37:1495-507.
2. Maheux P, Jeppesen J, Sheu WHH., Hollenbeck CB, Clinkingbeard C, Greenfield MS, Chen Y-D I, Reaven GM. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance. Hypertension 1994; 24:695-8.
3. Pyorala K. Relationships of glucose intolerance and plasma insulin to the incidence of coronary artery disease: results from two population studies in Finland. Diabetes Care 1979; 2:131-41.
4. Ducimitiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Roselin G. Relationship of plasma insulin concentrations to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19:205-10.
5. Stout RW. Insulin and atheroma. Diabetes Care 1989; 13:631-6.
6. Després J-P, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinaemia as an independent risk factor for ischaemic heart disease. New Engl J Med 1996; 334:952-7.
7. Pinkney JH, Mohamed-Ali V, Denver E, Foster C, Sampson MJ, Yudkin JS. Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes. Hypertension 1994; 24:362-7.
8. Berglund G, Larsson B, Andersson O. Body composition and glucose metabolism in hypertensive middle-aged men. Acta Med Scand 1976; 200:163-9.
9. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75:809-17.
10. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects: The San Antonio Heart Study. Diabetes 1993; 42:154-61.
11. Jiang X, Srinivasa SR, Bao W, Berenson GS. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents. The Bogalusa Heart Study. Am J Hypertension 1993; 6:564-9.
12. Feskens EJM, Tuomilehto J, Stengard JH, Pekkanen J, Nissinen A, Kromhout D. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia 1995; 38:839-47.
13. Mbanya JC, Thomas TH, Wilkinson R, Alberti KGMM, Taylor R. Hypertension and hyperinsulinaemia: a relationship in diabetes but not in essential hypertension. Lancet 1988; i:733-44.
14. Asch S, Wingard DL, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol; 1:231-44.
15. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio, M, Ravussin, M, Knowler WC, Bennett PH, Howard BV. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324:733-9.
16. Dowse GK, Collins VR, Alberti KGM, Zimmet PZ, Tuomilehto J, Chitson P, Gareeboo H. Insulin and blood pressure concentrations are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. J Hypertension 1993; 11:297-307.
17. Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R. An epidemiological test of the hyperinsulinaemia-hypertension hypothesis. J Clin Endocrin Metab 1993; 76, 544-8.
18. Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray P, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple R, Hales CN. Sensitive and specific two-site immunoradiometric assays (IEMA) for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989; 260:535-41.
19. Alpha B, Cox L, Crowther N, Clark PMS, Hales CN. Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem 1992; 30:27-32
20. Hales CN. The pathogenesis of NIDDM. Diabetologia 1994; 37 (Suppl 2):S162-8.
21. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH. Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 1992; 15:666-92.
22. Haffner SM, Mykkanen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes 1993; 42:1297-302.
23. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - evidence against a modulating role for insulin. Diabetologia 1995; 38:1110-16.
24. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clarke PMS, Schneider AG, Hales CN, Yudkin JS. The relationship of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1990; 33:532-7.
25. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at 64 years. Br Med J 1991; 303:1019-22.
26. Keen H. Insulin resistance and the prevention of diabetes mellitus. N Engl J Med 1994; 331:1226-7.
27. DeFronzo RA, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-23.
28. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycaemic glucose clamp. J Clin Invest 1987; 79:790-800.
29. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measures in medical research. Br Med J 1990; 300:230-5.
30. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; i:1336-7.
31. Winocour PH, Kaluvya S, Brown L, Farrer M., Millar JP, Neil H, Alberti KGMM. The association of different measures of insulinaemia with vascular risk factors in healthy normoglycaemic normotensive non-obese men and women. Q J Med 1991; 79:539-60.
32. Bavenholm P, Proudler A, Tornvall P, Godlsand I, Landou C, DeFaire U, Hamsten A. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 1995; 92:1422-9.
33. Morris AD, Petrie JR, Connell JMC. Insulin and hypertension. J Hypertension 1994; 12:633-42.
34. Grootenhuis PA, Mooy JM, Popp-Snijders C, Bouter LM, Heine RJ. Proinsulin like molecules in relation to blood lipids and blood pressure in a general Caucasian population, (abstract). Diabetologia 1993; 36 (Suppl 1):A270
35. Haffner SM, Mykkanen L, Valdez RA, Stern MP. Evaluation of two insulin assays in insulin resistance syndrome (Syndrome X). Arterioscler Thrombosis 1994; 14:1430-7.
36. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer H.M, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K. Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 1996; 45:242-56.
37. Matthews DR, Hosker JP, Rudenski JS, Naylor BA, Treacher BF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-19.